IFNG and diabetes mellitus: Multiple-antioxidant therapy prevented higher expression of tumor necrosis factor alpha (TNF-α), interferon gamma (IFN-γ), and ROS-producing enzymes in a type 1 diabetes mellitus (T1DM) model [194], clearly supporting an association of oxidative stress, inflammation, and diabetic complications.